Suven Life Sciences secures product patents in Canada, USA

23 Aug 2018 Evaluate

Suven Life Sciences has secured one product patent from Canada and one process patent from USA, corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2034.

The granted claims of the patents include the class of selective 5-HT6 compounds respectively and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia and sleep disorders like Narcolepsy etc.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

Suven Life Sciences Share Price

129.00 -4.50 (-3.37%)
27-Jan-2026 10:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.40
Dr. Reddys Lab 1241.25
Cipla 1302.10
Zydus Lifesciences 892.00
Lupin 2147.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×